WHO ICTRP trial
A phase 2 study for PD-1 antibody JS001 in Participants With Microsatellite…
ChiCTR1900022491 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting
Key facts
| Trial ID | ChiCTR1900022491 |
|---|---|
| Public title | A phase 2 study for PD-1 antibody JS001 in Participants With Microsatellite Instability-High (MSI-H) advanced or recurrent colorectal cancer |
| Scientific title | A phase 2 study for PD-1 antibody JS001 in Participants With Microsatellite Instability-High (MSI-H) advanced or recurrent colorectal cancer |
| Primary sponsor | Fudan University Zhongshan Hospital |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Not Recruiting |
| Study type | Observational study |
| Phase | 2 |
| Countries | China |
| Conditions | Colorectal cancer |
| Interventions | 1:JS001 |
| Registration date | Apr 13, 2019 |
| Target size | 1:40 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: